Skip to main content

Drug Interactions between bleomycin and indium pentetreotide in-111

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

bleomycin indium pentetreotide In-111

Applies to: bleomycin and indium pentetreotide in-111

Using bleomycin together with indium pentetreotide In-111 may cause indium pentetreotide In-111 to accumulate in the lungs leading to toxicity. This combination may also interfere with the results of tests using indium pentetreotide In-111. Drink plenty of fluids prior to receiving indium pentetreotide In-111 to help protect the lungs and other target organs (e.G., thyroid, kidneys, bladder). You should continue extra fluids and void frequently for one day after the indium pentetreotide In-111 test. You may also be instructed to take a mild laxative (e.G., bisacodyl or lactulose) before and after administration of indium pentetreotide In-111. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer